Gisela Schwab - Net Worth and Insider Trading

Gisela Schwab Net Worth

The estimated net worth of Gisela Schwab is at least $14 Million dollars as of 2024-05-04. Gisela Schwab is the Pres, Prod Dev & Med Aff & CMO of Exelixis Inc and owns about 628,362 shares of Exelixis Inc (EXEL) stock worth over $14 Million. Details can be seen in Gisela Schwab's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gisela Schwab has not made any transactions after 2021-04-26 and currently still holds the listed stock(s).

Transaction Summary of Gisela Schwab

To

Gisela Schwab Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gisela Schwab owns 3 companies in total, including Exelixis Inc (EXEL) , Genocea Biosciences Inc (GNCAQ) , and Genocea Biosciences Inc (GGNNQ) .

Click here to see the complete history of Gisela Schwab’s form 4 insider trades.

Insider Ownership Summary of Gisela Schwab

Ticker Comapny Transaction Date Type of Owner
EXEL Exelixis Inc 2021-04-26 EVP and Chief Medical Officer
GNCAQ Genocea Biosciences Inc 2020-02-14 director
GGNNQ Genocea Biosciences Inc 2020-02-14 director

Gisela Schwab Latest Holdings Summary

Gisela Schwab currently owns a total of 1 stock. Gisela Schwab owns 628,362 shares of Exelixis Inc (EXEL) as of April 26, 2021, with a value of $14 Million.

Latest Holdings of Gisela Schwab

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EXEL Exelixis Inc 2021-04-26 628,362 21.90 13,761,128

Holding Weightings of Gisela Schwab


Gisela Schwab Form 4 Trading Tracker

According to the SEC Form 4 filings, Gisela Schwab has made a total of 12 transactions in Exelixis Inc (EXEL) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Exelixis Inc is the sale of 50,000 shares on April 26, 2021, which brought Gisela Schwab around $1 Million.

Insider Trading History of Gisela Schwab

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gisela Schwab Trading Performance

GuruFocus tracks the stock performance after each of Gisela Schwab's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gisela Schwab is 8.6%. GuruFocus also compares Gisela Schwab's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gisela Schwab within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gisela Schwab's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gisela Schwab

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.95
Relative Return to S&P 500(%) 6.17

Gisela Schwab Ownership Network

Ownership Network List of Gisela Schwab

No Data

Ownership Network Relation of Gisela Schwab


Gisela Schwab Owned Company Details

What does Exelixis Inc do?

Who are the key executives at Exelixis Inc?

Gisela Schwab is the EVP and Chief Medical Officer of Exelixis Inc. Other key executives at Exelixis Inc include Sr. Vice President & Commercial Patrick J. Haley , EVP and General Counsel Jeffrey Hessekiel , and CSO/EVP Disc & Trans Research Dana Aftab .

Exelixis Inc (EXEL) Insider Trades Summary

Over the past 18 months, Gisela Schwab made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 247,500 shares made by Jeffrey Hessekiel , a net sale of 166,722 shares made by Patrick J. Haley , and a net purchase of 190,000 shares made by David Edward Johnson .

In summary, during the past 3 months, insiders sold 66,225 shares of Exelixis Inc (EXEL) in total and bought 190,000 shares, with a net purchase of 123,775 shares. During the past 18 months, 916,236 shares of Exelixis Inc (EXEL) were sold and 310,409 shares were bought by its insiders, resulting in a net sale of 605,827 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exelixis Inc Insider Transactions

No Available Data

Gisela Schwab Mailing Address

Above is the net worth, insider trading, and ownership report for Gisela Schwab. You might contact Gisela Schwab via mailing address: 6701 Kaiser Drive, Fremont Ca 94555.

Discussions on Gisela Schwab

No discussions yet.